Christina M Clarke1, Tessa Cheng2, Kathleen G Reims3, Clemens M Steinbock4, Meaghan Thumath5, Robert Sam Milligan6, Rolando Barrios7. 1. BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada. 2. Department of Urban Health Research Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada. 3. Department of Family Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA. 4. National Quality Center, New York State Department of Health AIDS Institute, New York, New York, USA. 5. BC Centre for Disease Control, Provincial Health Services Authority, Vancouver, British Columbia, Canada School of Nursing, University of British Columbia, Vancouver, British Columbia, Canada. 6. Department of Blood Borne Pathogens, Chronic Disease, Northern Health, Prince George, British Columbia, Canada. 7. BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
BACKGROUND: Rapid scale-up of effective antiretroviral therapy (ART) is required to meet global targets to eliminate new HIV infections and AIDS-related deaths. Yet, gaps persist in all nations striving for these targets. In the intervention setting of British Columbia (BC), Canada, where ART is publicly funded, 73% of HIV-diagnosed were on ART in 2011, and only 49% were achieving viral suppression. METHODS: An observational case descriptive study of HIV care sites in BC recruited to participate in a 35-month Breakthrough Series Quality Improvement Collaborative and sustainability network. Sites collected four quality indicators, qualitative change descriptions and implemented the chronic care model (CCM) and HIV care and treatment guidelines. Two reviewers assigned monthly implementation scores to evaluate site progress (January 2011-2012). All quality indicators were pooled and analysed using probability-based run chart rules. RESULTS: Seventeen teams with a pooled median population of 2296 HIV patients joined the initiative. Comprehensive CCM implementation and evidence of improvement was achieved by 29% of sites (implementation score of 4.0 or higher on 5.0 scale). Evidence of sustained improvement was observed for patient engagement (88.8-90.4%), ART uptake among patients unequivocally in need (92.9-94.8%), and ART uptake (≥6 months) and achieving viral suppression (57.3-78.4%) (all p<0.05). CONCLUSIONS: This study shows evidence of sustained improvements in HIV care processes and treatment outcomes for an estimated population of 2296 HIV patients in 17 BC sites. Overall success points to opportunities for other high-income countries seeking to improve HIV health outcomes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Rapid scale-up of effective antiretroviral therapy (ART) is required to meet global targets to eliminate new HIV infections and AIDS-related deaths. Yet, gaps persist in all nations striving for these targets. In the intervention setting of British Columbia (BC), Canada, where ART is publicly funded, 73% of HIV-diagnosed were on ART in 2011, and only 49% were achieving viral suppression. METHODS: An observational case descriptive study of HIV care sites in BC recruited to participate in a 35-month Breakthrough Series Quality Improvement Collaborative and sustainability network. Sites collected four quality indicators, qualitative change descriptions and implemented the chronic care model (CCM) and HIV care and treatment guidelines. Two reviewers assigned monthly implementation scores to evaluate site progress (January 2011-2012). All quality indicators were pooled and analysed using probability-based run chart rules. RESULTS: Seventeen teams with a pooled median population of 2296 HIV patients joined the initiative. Comprehensive CCM implementation and evidence of improvement was achieved by 29% of sites (implementation score of 4.0 or higher on 5.0 scale). Evidence of sustained improvement was observed for patient engagement (88.8-90.4%), ART uptake among patients unequivocally in need (92.9-94.8%), and ART uptake (≥6 months) and achieving viral suppression (57.3-78.4%) (all p<0.05). CONCLUSIONS: This study shows evidence of sustained improvements in HIV care processes and treatment outcomes for an estimated population of 2296 HIV patients in 17 BC sites. Overall success points to opportunities for other high-income countries seeking to improve HIV health outcomes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Chronic disease management; Collaborative, breakthrough groups; Control charts, run charts; Primary care; Quality improvement
Authors: Tessa Tattersall; Clara Tam; David Moore; Tim Wesseling; Sean Grieve; Lu Wang; Nic Bacani; Julio S G Montaner; Robert S Hogg; Rolando Barrios; Kate Salters Journal: BMC Public Health Date: 2022-05-21 Impact factor: 4.135
Authors: Francesca Celletti; Jennifer Cohn; Catherine Connor; Stephen Lee; Anja Giphart; Julio Montaner Journal: J Int AIDS Soc Date: 2016-12-16 Impact factor: 5.396
Authors: Michelle Olding; Ben Enns; Dimitra Panagiotoglou; Jean Shoveller; P Richard Harrigan; Rolando Barrios; Thomas Kerr; Julio S G Montaner; Bohdan Nosyk Journal: J Int AIDS Soc Date: 2017-09-19 Impact factor: 5.396
Authors: Elizabeth A McCarthy; Hamsa L Subramaniam; Margaret L Prust; Marta R Prescott; Felton Mpasela; Albert Mwango; Leah Namonje; Crispin Moyo; Benjamin Chibuye; Jan Willem van den Broek; Lindsey Hehman; Sarah Moberley Journal: PLoS One Date: 2017-04-18 Impact factor: 3.240